Product
Currency:CNY
2024/H1
Stock NameRevenueRatio
Lipoic acid series143.4M66.19%
Carnosine series26.89M12.41%
Phosphatidylcholine series25.23M11.65%
Total special adjustments19.71M9.10%
Other business1.41M0.65%
Industry
Currency:CNY
2023/FY
Stock NameRevenueRatio
Pharmaceutical main business483.1M98.73%
Other6.19M1.27%
Region
Currency:CNY
2023/FY
Stock NameRevenueRatio
Abroad307.89M62.93%
Other181.4M37.07%